A Study in Healthy Men to Test Whether Zongertinib Influences the Amount of 4 Other Medicines (Dabigatran, Rosuvastatin, Metformin, and Furosemide) in the Blood

NCT06504862 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Zongertinib
DRUG: Dabigatran-etexilate
DRUG: Rosuvastatin
DRUG: Metformin hydrochloride
DRUG: Furosemide

Sponsor

Boehringer Ingelheim